Encompass Health (EHC) | Stock Overview & Key Data
Encompass Health Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $127.99 on October 24, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Encompass Health
EHC
|
10.25B Large-cap | -1.73% | -6.83% | -2.04% | -7.65% | -6.59% | -16.09% | 55.92% | 60.05% | 221.72% | 399.85% | 545.89% |
|
HCA Healthcare
HCA
|
106.00B Large-cap | 7.93% | -7.81% | -25.75% | -18.24% | -17.10% | 4.31% | 33.47% | 92.28% | 400.04% | 1,019.34% | 1,144.15% |
|
Tenet Healthcare
THC
|
16.50B Large-cap | 9.88% | -8.92% | -18.33% | -9.23% | -10.20% | 6.26% | 122.70% | 164.92% | 543.08% | 581.20% | 489.27% |
|
Universal Health
UHS
|
11.07B Large-cap | 2.17% | -13.44% | -24.55% | -34.80% | -33.61% | -14.41% | -1.48% | -0.20% | 11.56% | 181.90% | 492.07% |
|
Ensign Group
ENSG
|
11.06B Large-cap | -3.65% | -15.17% | -28.05% | -14.90% | -13.35% | -1.24% | 57.98% | 79.14% | 733.07% | 1,721.59% | 3,525.49% |
|
DaVita
DVA
|
10.01B Large-cap | 9.20% | 5.01% | 41.51% | 74.72% | 83.17% | 53.29% | 113.75% | 71.55% | 177.81% | 396.45% | 753.76% |
Ownership & Short Interest
Calculate Your Encompass Health Investment Returns
Long-Term Investment Performance Analysis
Encompass Health stock price in Jul 2016 was $32.45, A $1,000.00 lump sum investment in Encompass Health made 9 years ago would be worth approximately $3,061.94 today, representing a outstanding return of 206.19%. This translates to an annualized return (CAGR) of 11.96%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is EHC's 52-week high and low?
- In the last 52 weeks, Encompass Health reached a high of $127.99 (on N/A) and a low of $92.77 (on February 3, 2026).
- What is the market cap and P/E ratio for EHC?
- Curious about Encompass Health's size and valuation? Its market capitalization stands at 10.25B. When it comes to valuation, the P/E ratio (trailing twelve months) is 18.52, and the forward P/E (looking ahead) is 15.86.
- Does EHC pay dividends? If so, what's the yield?
- Yes, Encompass Health is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.68%, and the company has paid an average of $0.65 per share annually over the past 3 years.
- Who are Encompass Health's main competitors or similar companies to consider before investing?
When looking at Encompass Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return HCA Healthcare
HCA106.00B Healthcare Medical Care Facilities 4.31% 33.47% Tenet Healthcare
THC16.50B Healthcare Medical Care Facilities 6.26% 122.70% Universal Health
UHS11.07B Healthcare Medical Care Facilities -14.41% -1.48% Ensign Group
ENSG11.06B Healthcare Medical Care Facilities -1.24% 57.98% DaVita
DVA10.01B Healthcare Medical Care Facilities 53.29% 113.75% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Encompass Health Corporation? (e.g., ROE, Debt/Equity)
- To get a sense of Encompass Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 24.82%, the Debt to Equity ratio from the most recent quarter is 82.85, and its Gross Profit Margin stands at 95.82%.
- What is the recent revenue and earnings growth for EHC?
- Looking at Encompass Health's growth, its revenue over the trailing twelve months (TTM) was $6B. Compared to the same quarter last year (YoY), quarterly revenue grew by 9.90%, and quarterly earnings saw a YoY growth of 20.80%.
- How much of EHC stock is held by insiders and institutions?
- Wondering who owns Encompass Health stock? Company insiders (like executives and directors) hold about 1.05% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 102.10%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.